Coherus Oncology Inc (CHRS)

Financing Cash Flow

$115.41M

TTM · Period ending: · USD

CHRS logo

CHRS Financing Cash Flow

Latest reported$115.41M
CHRS TTM Cash from Financing ($9.96M → $115.41M)
High-resolution chart · PNG

CHRS financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
115,407,000
-219,851,000
-273,705,000
-281,555,000
-281,724,000
-188,125,000
-186,974,000
-186,839,000
-175,567,000
66,683,000
69,600,000
75,827,000
113,589,000
59,985,000
54,326,000
49,220,000
1,454,000
47,585,000
51,879,000
55,905,000
58,892,000
222,462,000
223,946,000
219,633,000
219,228,000
11,816,000
89,370,000
90,763,000
88,138,000
185,020,000
105,421,000
109,720,000
183,744,000
83,668,000
206,787,000
255,894,000
182,066,000
251,333,000
226,179,000
170,510,000
179,719,000
223,261,000
122,689,000
206,125,000
193,878,000
135,219,000
135,956,000
52,190,000
63,930,000
9,964,000
9,956,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.